Repligen Corporation - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Repligen Corporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Repligen Corporation. The Group's principal activity is to develop novel therapeutics primarily for radiology and neuropsychiatry. It currently sells a line of commercial products based on Protein A, which are used in the production of monoclonal antibodies. The Group manufactures and markets several products based on recombinant forms of Protein A. Its primary customers incorporate its Protein A products into their proprietary monoclonal antibody purification products that they sell directly to the biotechnology and pharmaceutical industry.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report